Schiodt, Morten
Vadhan-Raj, Saroj
Chambers, Mark S.
Nicolatou-Galitis, Ourania
Politis, Constantinus
Coropciuc, Ruxandra
Fedele, Stefano
Jandial, Danielle
Zhang, Jeffrey
Ma, Haijun
Saunders, Deborah P.
Funding for this research was provided by:
Amgen Inc.
Article History
Received: 28 December 2016
Accepted: 3 December 2017
First Online: 23 December 2017
Compliance with ethical standards
: All patients provided informed consent.
: DPS is a global advisor and investigator for Amgen and has received honoraria from Pfizer. SV-R received honoraria and research funding from Amgen. MSC and RC have no disclosures. ON-G has received travel support from Novartis and travel support and honoraria from Amgen. CP has participated as an investigator in an Amgen trial. SF has received research funding and travel support and honoraria from Amgen and salary support from the National Institute for Health Research (NIHR). DJ, JZ, and HM are employees of and own stock in Amgen. MS has served as a consultant to and received honoraria from Amgen.
: The study protocol was reviewed and approved by an independent ethics committee or institutional review board at each study center before enrollment of patients at that center.